Biotechblog – Page 1035 – Biotechnology business, policy, and more!

Creative Destruction in Biotechnology

For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming […]

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products

John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH

The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th

Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not

I’ll be giving a talk at the Johns Hopkins Carey Business School Entrepreneurship Conference on March 21st titled “Entrepreneurship: What

The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited

I am extending my “Best Practices in Biotechnology” book series with additional books in specific niches in biotechnology commercialization. This

I’ll be giving a talk at the Kogod School of Business on Tuesday February 24th on “Drug Development – Balancing